MYD88 and melanoma: Notably, Xiu Qiong Fu et al. showed that TLR4 ligands activate STAT3 through MyD88 in melanoma cells and that knockdown of MyD88 reduced the level of STAT3 phosphorylation without affecting total STAT3 protein levels [52].